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IN a preceding paper (Neish and Rylett, 1960) it was noted that an unidentified
ninhydrin-positive spot X appeared in electropherograms of phosphate buffer
extracts of livers of male rats which had been injected intraperitoneally with
powerful hepatocarcinogens. Spot X was observed in the early stages of action
of the hepatocarcinogens when the livers contained high levels of phosphoethano-
lamine. Another unidentified spot Y sometimes accompanied X in these electro-
pherograms.
Intraperitoneal injections of weak hepatocarcinogens or of non-hepatocarcino-
gens (e g. 2-methyl-4-dimethylaminoazobenzene and carbon tetrachloride) failed
to promote the appearance of X or Y in rat liver. Traces of X but never of Y
were sometimes found in extracts of livers of normal rats, both male and female.
Spots X and Y migrated towards the anode on Whatman No. 1 paper saturated
with barbitone buffer (pH 8*6; 360 volts; 3 hours) and, with respect to easily
identifiable spots due to phosphoethanolamine (PE), glutathione (GSH), glutamic
acid (glu) and aspartic acid (asp), they occupied the following positions on the
electropherograms:
X, PE + GSH, glu, asp and Y,
with Y lying nearest to the anode.
It was of interest to identify X and Y which may be abnormal metabolic
products of liver or normal metabolic products in abnormally larg& amounts and
also to determine whether X and Y can be detected in rat liver under other
experimental conditions and in the livers and organs of other species.
Substance X and appreciable amounts ofY werefound in extracts ofthespleens
of rats injected with 3'-methyl-4-dimethylaminoazobenzene (3'-MeDAB). They
were absent in extracts ofthe kidneys ofthese rats and they could not be detected
in spleen or kidneys of normal rats.
A spot corresponding to X was found in the livers ofrats bearing transplantable
or induced tumours and it also appeared frequently in extracts of the tumours
themselves. Although spot Y was never detected in extracts of livers of tumour-
bearing rats, a substance with the same mobility was seen regularly inthe tumour
extracts. Sometimes in electropherograms of extracts of livers from tumour
rats but never in normal rat liver extracts there appeared a ninhydrin-positive
spot Z which had a lower mobility than spot X under the standard conditions of
electrophoresis. A spot similar to Z occurred in extracts of all the tumours
examined.
Electropherograms of extracts of livers of normal male guinea-pigs contained
appreciable amounts of substance X and also materials corresponding to Y and Z.A THIOL PEPTIDE FROMN RAT LIVERS
Although guinea-pig liver substance X seems to be identical in every respect witl
the rat liver substance X induced by a powerful hepatocarcinogen such as 3'-
MeDAB, intraperitoneal injection of this carcinogen into a male guiniea-pig failed
to cause any noticeable elevation in the level of substance X.
Evidence has been obtained that spot X from hepatocarcinogen-treated rat
liver, from the livers of rats bearing tumours and from normal guinea-pig liver is
a thiol peptide closely related to but not identical with glutathione. Very few
studies of spot Y have been made but it seems that this substance also may be a
thiol peptide.
Tumour Z spot appears to be a protein or polypeptide particularly rich in
glutamic acid, aspartic acid, glycine and cysteic acid. Chromatography of
hydrolysates of Z shows that it has approximately the same qualitative and
quantitative amino acid composition whether it is derived from slow or rapidly
growing transplantable tumours or from chemically-induced tumours. On the
other hand, Z spots observed in the electrophoresis ofextracts oftissues other than
tumours seem to be due to cysteine or cystine.
Some preliminary observations on the nature of spots X, Y and Z form the
subject of the present paper.
EXPERIMENTAL
A description of experimental procedures has already been given (Neish and
Rylett, 1960). Slow growing transplantable rat tumours originally induced with
9, 10-dimethyl-1, 2-benzanthracene (DMBA) and some rapidly growing long-
established transplantable Rd/3 rat sarcomas were examined. Several chemically-
induced (3, 4-benzopyrene; BP) rat tumours were available for study.
The tumour-bearing animals were killed with ether and the livers perfused
with chilled normal saline. Tumours, livers and other organs were stored at
-150 C. Phosphate buffer (pH 7.2) extracts of fresh tumour tissue were pre-
pared as previously described for liver. In a similar manner, extracts were
prepared from the perfused liver and other organs of guinea-pigs.
In agreement with Sauberlich and Baumann (1951) it was found that all the
tumours had a low dry weight percentage ranging from about 12 to 16 per cent of
the tissue wet weight. Livers oftumour-bearing rats had a dry weight content of
about 28 per cent, the same as for normal rat liver.
RESULTS
1. lTature of substance X
(a) Detection of substance X2 by paper electrophoresis.-Fig. 1 (A and B) illus-
trates the occurrence of spot X in extracts of male rat livers 4 days after intra-
peritoneal injection of the hepatocarcinogen, 3'-methyl-4-dimethylaminoazoben-
zene (3'-MeDAB; 16*5 mg. in 0-6 ml. of arachis oil per 100 g. body weight).
Spot X is absent or barely detectable in comparable extracts of the livers of
normal male rats (Fig. 1, C and D) which received arachis oil only. For comn-
parison, an electropherogram of an extract of normal male guinea-pig liver in
which spot X is prominent is shown in Fig. 1 E. In this separation spots Y and
Z can also be seen.
(b) Two dimensional chromatography of substance X and its hydrolysis
products.-Paper sections corresponding to the position of the ninhydrin-positive
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spot X were cut from 3 separate parallel electropherograms (each obtained fromli
0.01 ml. of liver homogenate supernatant) and the strips were eluted with de-
ionised water. The aqueous extracts were freeze-dried and the residues were
subjected directly or after acid hydrolysis (0.1 ml. of 6 N HCO in sealed tubes at
110° C. for 24 hours followed by freeze-drying) to two dimensional chromato-
graphy in Bowden's system (Bowden, 1959) using the modified Datta frame for
miultiple separations as previously described (Neish and Rylett, 1960).
The hydrolysed and unhydrolysed residues were extracted with small volumes
of deionised water and these extracts, which contained undissolved fine white
crystalline material (evidently barbitone buffer components and their hydrolysis
products) were applied at the origin of the paper chromatograms. Apparently,
the suspended material did not interfere markedly with the separation of amino
acids. However, allowance had to be made for the occurrence of several nin-
hydrin-positive artifacts which were detected as follows. Chromatography of
hydrolysed and unhydrolysed residues obtained from strips of blank electro-
pherograms (taken from the anode side of the paper at regions where X and GSH
are usually located) revealed that hydrolysed residues contain a substance which
gives a small palepurple ninhydrin-positive spot with Rf values (phenol, 0-29:
butanol, 0.15) approximately the same as those given by glutamic acid, while
unhydrolysed material gives an orange-yellow ninhydrin positive spot with Rf
0*30 inphenol and0(38 in butanol. Unhydrolysed barbitone residues also yielded
ayellow diffuse spot which was seen after the phenol run (Rf 069). This coloured
spot disappeared after the butanol run and no ninhydrin-positive material corres-
ponding to it could be detected in the chromatograms.
The yellow ninhydrin-positive spot (N) can be seen in a chromatogram of
unhydrolysed extract of spot X (Fig. 2A). The very small pale purple barbitone
artifact is obscured bv the stronger glutamic spot which occurs in hydrolysates
of X orGSH.
In Fig. 2 are shown chromatograms of unhydrolysed X substance (A) and of
hydrolysed X substance (B) obtained from electropherograms of 3'-MeDAB-
treated rat liver. The products ofhydrolysis of X substance from normal guinea-
pig liver are seen in chromatogram D. Unhydrolysed guinea-pig liver X substance
gave a chromatogram similar to Fig. 2A. Fig. 2C shows the chromatographic
behaviour ofthe hydrolysate obtained from an authentic sample ofGSH which had
been processed electrophoretically exactly as described for substance X. Un-
hvdrolysed GSH gave a chromatogram identical with Fig. 2A.
Unhydrolysed X or GSH each gave a single pale purple spot with about the
same Rt values. These substances did not contain free thiol groups since the
addition of N-ethvlmaleimide (see later) to extracts containing them had no
effect on their two dimensional coordinates. The substances had about the same
Rf values as the sulphonic acid derivative of GSH (GSO3H) a specimen of which
was prepared by performic acid oxidation of GSH according to Kermack and
Matheson (1957). Synthetic GSO3H moves towards the anode with greater
miiobility than GSH. Evidently GSH and substance X undergo oxidation to
derivatives similar to GSO3H during their removal from the electropherograms.
Fig. 2B, 2C and 2D each show three ninhydrin-positive spots due to glycine
(reddish) glutamic acid (strong purple) and cysteic acid (pale purple). The latter
spot has a low Rf value in phenol and, in the butanol direction its Rf value is a
little greater than that of synthetic GSO3H, of unhydrolysed X (Fig. 2A) or of
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({SH processed electrop)horetically. Its Rf values are identical with those giveen
by authentic cysteic acid (and incidentally with those of homocysteic acid).
Thuis it seems that substance X from hepatocarcinogen-treated rat liver or
f'rom normal guinea-pig liver has the same qualitative but apparently not the
same quantitative amino acid composition as glutathione. X is not identical
with authentic gluitathione because the latter (applied to electropherograms as a
solutioni in pH 7-2 phosphate buffer) miigrates ahead of X as a single spot to the
same positioIn as spot P (Fig. 1) occupied by phos)hoethanolamine and GSH
(derived from liver extracts.
(c) Presence of a free thiol yroup in substance -.-The followinlg exallmples
illustrate the use of N- ethylmaleimide (NE.M) in determining the thiol nature of
substance X derived from fresh phosphate extracts of a number of tissues and
also serve to demonstrate the occurrence of other uinknown ninhydrin-positive
materials Y and Z mentioned in the introduction.
A normal male guinea-pig (1000 g.) received an intraperitoneal injection of
G mil. of arachis oil and another male guinea-pig (965 g.) was injected intra-
peritoneally with a solution of 3'-MeDAB (159 mg.) in arachis oil (6 ml.) The
animals were killed 4 days after injection. Thus the conditions were comparable
wx-ith those obtaining in the rat experiment illustrated by Fig. 1.
In Fig. 3 are shown electropherograms of 0.01 ml. aliquots of phosphate
extracts of the normal (A) and 3'-MeDAB-injected (C) guinea-pig livers and of
O>-0 ml. aliquots of 1 ml. portions of the same phosphate extracts to wllich a few
crystals of NEM had been added jllst before electrophoresis (Fig. 3, B and 1)
respectively).
Spot X is promninent in extracts of both nornmal and hepatocarcinogen-treated
livers and it is evident that the carcinogen has failed to produce any major increase
in the amount of X in guinea-pig liver such as was found in the case of rat liver
(Fig. 1). Addition of NEM to phosphate extracts of guinea-pig liver led to the
lisappearance of X, a diminution in the intensity of spot P (PE + GSH) and
to the appearance of a new spot Z'. It will be noted that the liver electrophero-
grams already contain a composite spot which is termed Z in approximately the
region at which Z' appears. Following the addition of NEM (Fig. 3B) spot Z
(or part of it) disappears and is replaced by a spot of lower mobilitv marked Z
+ NEM. There is reason to believe that spot Z may be due to cysteine -
cystine and that Z + NEINI represents the reaction product of NEM with
cysteine. Without discussing the behaviour of all of these spots at present it mav
l)e remarked that spot Z' appears to consist of the reaction products of NEM with
the unknown substance X and with the GSH portion of the composite spot })
which contains PE, GSH and possibly also some oxidised glutathione, GSSGC.
In Fig. 4 a substance corresponding to X is seen in the electropherogram A
of a fresh extract of the liver of a rat bearing a transplantable Rd/3 sarcoma and
also in the electropherogram C of an extract of the tumour itself. Addition
of NEMI to these extracts resulted in the disappearance of spot X, diminution
in the intensity of spot P and the appearance of a new spot Z'. Note that a spot
Z is already present in the tumour extract (Fig 4(1).
Precisely the same effects were observed in electropherograms of freshextracts
of hepatocarcinogen-treated rat liver to which NEM had been addedjustbefore
electrophoresis namely spot X disappeared, spot P diminished in intensity and
a nem ninhvdrin-positive spot with mobility Z' appeared.
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EXPLANATION OF PLATES
FIG. 1. Electropherograiis of phosphate extracts of:
A and B rat liver 4 days after injection of 3'-MeDAB in arachis oil.
C and D rat liver 4 days after injection of arachis oil.
E-normal guinea-pig liver.
X, Y and Z-explained in text.
P = spot due to phosphoethanolamine + glutathione.
GLU glutamic acid.
ASP aspartic acid.
Note: low level of aspartic acid in guinea-pig liver as compared with rat liver.
Fic. 2. Two-dimensional chromatogram of:
A unhydrolysed X spotl from phosphate extract ofliver of rat injected with 3'-MNeDAB. B hydrolysed X spot f
C hydrolysate of glutathione processed electrophoretically.
D--hydrolysed X spot from normal guinea-pig liver.
N = barbitone artifact.
CYS = cysteic acid.
Vertical arrows show direction of phenol--water (4: 1) run.
Horizontal arrows show direction of butanol-methyl ethyl ketone-dicycelohexylaiminle-
water (100: 100 : 20: 47) run.
FIG. 3. Electropherograms of phosphate extracts of:
A guinea-pig liver. 4 days after arachis oil injection.
B as for A, with N-ethylmaleimide added.
C--guinea-pig liver, 4 days after injection of 3'-MeDAB in arachis oil.
D as for C with N-ethyl maleimide added.
Fi(c. 4. Electropherograms of phosphate extracts of:
A-liver (8-4 g.) of female rat (total body weight = 171 g.) bearing R,d/3 sarcomia
(23 -2 g.)
B as for A with NEM added.
C Rd/3 sarcoma.
D-as for C with NEM added.
Note: high level of aspartic actid in liver as compared withl low level in tuniour.
Fi(c. .5. Electropherograms of:
GSH glutathione.
GSH + NEM = glutathione with NV-ethylmaleimide added.
GSA S-acetylglutathione.
GSA + NEM S-acetylglutathione with N-ethylmaleimide added.
FI(G,. 6. A. Electropherograms of:
GSH glutathione.
GSH + NEM glutathione +- N\-ethylmaleirnide.
GSH + UV
GSH + NSC fsee text.
Two-dimensional chromatograms of:
B uhydrolysed spot "X" from GSH +-UV. C-hydrolysed fSlO
D-unhydrolysed } t " X
" from GSH + NSC. E hydrolysed f so
Note traces of X and cvsteic acid. N = barbitone artefact.
Vertical and horizontal arrows indicate direction of flow of phenol aind butanol solvelnts
respectively.
FIc. 7. A. Electropherograms of phosphate buffer extract of a BP tumnour (1st transplanit
generation) before (BP) and after (BP + NEM) addition of NEM. Note failure of X to
respond to NEM addition. Phosphate buffer extract several weeks old.
Two-dimensional chromatograms of:
B-hydrolysate of Z spot (see Fig. 7A).
Note distortion of glutamic acid and aspartic acid spots, due to barbitone salts.
C-Reference chromatogram. 1 mg. of each amino acid in 3 ml. of phosphate buffem-
(pH 7.2). 0-01 ml. of mixture applied at origin.
ALA a-alanine GLY glycine SER serine
ARG arginine HIS histidine TAU taurine
ASP aspartic acid L,EU leucine VAL valine
CYS cysteic acid LYS lysine
GLU glutamic acid PRO proline
Vertical aTnd horizontal arrows indicate direction of flow of phenol and bl)tanol solvents
resp)ectively.BRITISH JOURNAL OF CANCER.
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Wthen authentic samples of GSH and of GSSG were submitted to electro-
phoresis both substances migrated to about the same position as spot P of the
tissue extracts. GSSGC formed a much more compact spot than did GSH and it
had a slightly greater mobility than GSH. However, mixtures ofGSH and GSSG
invariably gave a single spot. After incorporation of NEM into phosphate buffer
solutions of the pure materials, migration of GSSG was unaffected but the spot
lue to GSH was considerablv retarded with respect to GSSG and now occupied
position Z'.
Friedmann, Marrian and Siimon-Reuiss (1949) showed that NEM has a powerful
affinity for thiol compounds (RSH) which react by addition at the ethylene bond
of NEM to give products of the type:
R---S CH CO
N--CH2CH:3
CH2-CO
According to Gregory (1955) the rapid reaction between NEM and GSH can be
used for quantitative purposes. Although cysteine and H2S also react with NEM,
Gregory found that no reaction occurred with S-acetylglutathione, GSSG, ethanol,
ethylamine or HCN. In the present work we have confirmed that reaction of
NEM with naturally occurring ninhydrin-positive materials seems to be limited to
those substances which contain free thiol groups.
It is concluded that substance X in hepatocarcinogen-treated rat liver and in
normal guinea pig-liver is closely related to authentic GSH and that both com-
pounds contain a free thiol group capable of reacting with NEM.
(d) Attempted isolation of thiol peptide X along with GSH from the livers of
rats injected with 3'-JMeDAB.-Attempts were made to isolate thiol peptide X
along with GSH from perfused fresh livers of rats injected with 3'-MeDAB by the
cadmium chloride-cuprous mercaptide precipitation method of Waelsch and
Rittenberg (1941).
Although X was prominent in the 3'-MeDAB livers and virtually absent in
the normal control livers (Fig. 1 shows electropherograms of extracts of some of
the rat livers used in these experiments) electrophoresis of the final products
obtained by the action of H2S on aqueous suspensions of the cuprous mercaptide
prepared from the 3'-MeDAB liver failed to reveal any spot other than that due
to authentic GSH. Thus peptide X may be a labile derivative of GSH which
readily reverts to the parent substance during the isolation procedure.
Hydrolysis experiments were carried out with an authentic specimen of GSH
which had been submitted to the cuprous mercaptide isolation procedure (with
90 per cent recovery) and on GSH specimens prepared as described above from
livers of normal and 3'-MeDAB injected rats. No differences could be detected
in chromatograms of the hydrolysis products which in each case showed strong
spots due to glycine, glutamic acid, cysteine and/or cystine. It is interesting
that no cysteic acid was detected chromatographically in experiments in which
rather large amounts of the peptides were subjected to hydrolysis. The con-
centration of GSH in the hydrolysis medium was not without influence on the
nature of the hydrolytic products. Thus at a concentration of 4 ,ug of GSH per
01 ml. of 6 N HCI, 3 spots due to glycine, glutamic acid and cysteic acid were
detected whereas in hydrolysates containing initially 12 jtg of GSH per 0 I ml. of
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6 N HCl appreciable amounts of either cysteine or cystine were detected but only
traces of cysteic acid.
A pooled liver sample (15 g. ; 5 g. from each of 3 rats) from rats injected with
3'-MeDAB contained 167 mg. of GSH (regenerated from the cuprous mercaptide)
per 100 g. wet weight of liver, whereas a similar sample from 3 normal (arachis oil
injected) rats contained 123 mg. of GSH per 100 g. wet weight of liver.
The increase in rat liver GSH following intraperitoneal injection of 3'-MeDAB
is in accord with results of Fiala (1958) who showed that rat liver GSH increases
in the early stages of feeding this azo dye. A similar increase in the GSH con-
tent of mouse liver after intraperitoneal injection of the liver carcinogen, 3, 4: 5,
6-dibenzcarbazole, was observed by Boyland and Mawson (1938).
(e) Comparison of the electrophoretic behaviour of various GSH derivatives and
related products with that of thiol peptide X.-Since efforts to isolate substance X
had failed, attempts were made to gain further insight into its nature by com-
parative studies of the electrophoretic behaviour of solutions of known GSH
derivatives in pH 7.2 phosphate buffer.
It seemed possible that substance X might be S-acetylglutathione since
Benesch et al. (1960) have stated that this compound gives a colour reaction with
NEM which is said to be typical of a number of free thiol compounds and some
thiol esters but which is not given by thioethers. A sample of S-acetylgluta-
thione had the same mobility as substance X under our electrophoresis conditions.
However, as shown in Fig. 5, the mobility of this substance was unaffected by
NEM. Evidently, substance X is not S-acetylglutathione and it seems probable
that the colour reaction given by this substance may in fact be due to GSH formed
from the S-acetyl derivative in the preliminary reaction with NEM before colour
development with KOH. As noted by Gregory (1955) no spectroscopic evidence
could be obtained for a reaction between S-acetylglutathione and NEM.
It was of interest to compare the electrophoretic behaviour of S-methylgluta-
thione with that of S-acetylglutathione although the former was unlikely to be
identical with tissue substance X. S-methylglutathione was prepared by the
method of Kermack and Matheson (1957). Although this compound had a lower
mobility than GSH and about the same mobility as substance X it failed to react
with NEM. Similarly a specimen of S-benzylglutathione prepared as described
by Saunders (1934) had about the same mobility as X and was uninfluenced by
NEM. Thus when the thiol group of GSH is blocked by the groups acetyl,
methyl or benzyl the mobility of these derivatives is retarded as compared with
authentic GSH to about the same extent as X. Unlike X however, they failed
to react with NEM. It seems certain that the thiol group of peptide X is free.
Although hydrolytic studies have shown that peptide X apparently contains
the three amino acids, glycine, glutamic acid and cysteine, it seemed worthwhile
to check the electrophoretic behaviour of the dipeptides y-glutamyl-cysteine
and cysteinylglycine. These substances were prepared by methods given by
Gutcho and Laufer (1954). y-glutamylcysteine had about the same mobility as
glutamic acid. It reacted with NEM to give a single strong ninhydrin-positive
spot of diminished mobility at about position Z'. Similar results were obtained
with cysteinylglycine. Neither of these thiol dipeptides had the mobility of
thiol peptide X.
An indication that substance X might be an abnormal oxidation product of
GSH is contained in a paper by Blass, Le Comte and Polonovski (1954). These-
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authors noted 3 spots in electropherograms of GSH which had been treated with
hydrogen peroxide under unspecified conditions. One of the oxidation products
(probably GSO3H) lay ahead ofthe main GSH spot (probably GSSG) in the anode
direction while the other had a lower mobility than the main spot. Judging from
a diagram ofthe separation presented in their paper it appeared that the oxidation
product of low mobility had about the same mobility as substance X. Although
we were unable to detect any ofthe slow moving substance in a specimen of GSH
treated with hydrogen peroxide, we did observe that an old specimen ofGSH (not
treated with H202) gave a strong ninhydrin-positive spot in the usual position for
GSH and two slowly-developing weaker spots: a compact spot with greater
mobility than GSH and a diffuse spot with a lower mobility than the main spot.
However the mobility ofthe slow spot was rather less than that oftissue substance
X and was about equal to that of the GSH-NEM reaction product Z'. The fast
spot disappeared when NEM was added to the GSH stock solution but the mobility
of the slow spot was unaffected. Thus the fast material probably contains a free
thiol group whereas the slow moving spot evidently contains no such group.
It seemed of interest to investigate oxidation products of GSH arising in
other experimental situations and to this end electrophoretic studies were made of
ninhydrin-positive products resulting from (i) irradiation of a solution of GSH in
phosphate buffer (pH 7.2) with ultraviolet light and from (ii) a reaction between
GSH and napthalene-2-sulphonyl chloride (N-2-SO2Cl).
(i) Woodward (1933) found that GSH was oxidised mainly to GSSG byultra-
violet light at pH 7 but some degradation of GSH also occurred. This reaction
was reinvestigated with a solution of GSH (10 mg.) in pH 7-2 phosphate buffer
(4 ml.) which was exposed in a 1 cm. quartz cell for 4 hours at 20° C. to unshielded
light from the mercury arc of an Hanovia lamp, the mercury arc being about 6
inches from the cell. A suitable dilution of the irradiated solution (which had a
strong smell ofH2S) was preparedwith pH 7-2 buffer and aliquots with andwithout
NEM were submitted to paper electrophoresis. Fig. 6A shows a typical separa-
tion of ninhydrin-positive materials resulting from this reaction (GSH + UV).
For reference, GSH and its NEM reaction product have been included in the
electropherogram. The main spot marked " GSH " seems to consist entirely of
GSSG since its intensity was unchanged in a parallel run including NEM (not
shown in Fig. 6) and no new spot of lower mobility appeared. A second promin-
ent spot " X " having a lower mobility than the " GSH " spot occurred in the
region generally occupied by tissue X spot. Its intensity and position were un-
altered by NEM. Chromatographic analyses were made of unhydrolysed and
hydrolysed " GSH " and " X " materials. Spot " GSH " contained only gluta-
mic acid, glycine and cysteic acid and the chromatogram of the hydrolysate was
identical with that shown in Fig. 2C for authentic GSH. A control analysis of
authentic GSSG gave the same results. However it is clear from Fig. 6B and
6C that the substance "X " does not correspond to tissue substance X. It
gave a single strong purple spot with an Rf value of 0 37 in phenol (Fig. 6B).
On hydrolysis, 3 spots were obtained corresponding to glutamic acid, glycine and
x-alanine with Rf values in phenol of 0-28, 0-39 and 0-60 respectively (Fig. 6C).
Thus "X " could be identical with the tripeptide y-glutamylalanylglycine which
has been detected by Waley (1957) in bovine lens. DL-y-glutamyl-DL-alanyl-
glycine was synthesised according to Kermack and Matheson (1957) and
subjected to paper electrophoresis, elution and chromatographic analysis as
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already described. It had the same electrophoretic mobility as peptide"X".
The unhydrolysed material had Rf0O39 in phenol, and, on hydrolysis the peptide
gave 3 spotsdue to glutamic acid, glycine andac-alanine with Rf values of 030,
0-42 and0-62 respectively in phenol and the spots had the same relative intensities
as the spots seen in Fig. 6C. It is concluded that peptide "X"is y-glutamyl-
alanylglycine. It probably arose by loss of H2S from the cysteinyl residue of
GSHwith subsequent reduction of the resulting dehydroalanyl tripeptide to the
alanyl derivative.
(ii) Saunders (1933) investigated a peculiar reaction which occurred between
GSH and naphthalene-2-sulphonylchloride (N-SO2C1 or NSC). The latter failed
to react in the ordinary way with the amino group of GSH. Instead it promoted
an oxidation reaction and was itself reduced to naphthalene-2-sulphinic acid
(N-2-SO2H or NSH). On stoichiometric grounds Saunders concluded that the
main reaction product ought to be GSO2SG but his analysis of the ill-defined
product failed to support this view.
This reaction was reinvestigated and after removal of NSH by precipitation
with HCl, deep freezing and centrifugation, a portion of the yellowish acidic
supernatant smelling strongly of H2S was diluted with phosphate buffer (pH
7.2) and examined electrophoretically. A typical separation is shown in Fig.
6A (GSH + NSC). Analysis of the main spot "GSH "revealed that it probably
consists mainly of GSSG. Addition of NEM to the phosphate buffer solution
resulted in the development of a Z' spot, showing that some free thiol compound,
probably GSH, is still present in the reaction mixture. As in the case of GSH
+ UV there appeared a very faint red spot just on the cathode side of the origin
in the position to which authentic glycine migrates. These glycine spots cannot
be seen clearly in the autopositive reproduction, Fig. 6A.
The nature of the "X" spot observed in this separation is of considerable
interest although it is evidently quite different from tissue X spot. The un-
hydrolysed substance (Fig. 6D) gave a purple ninhydrin-positive spot with
RfO*32 in phenol. After acid hydrolysis, 2 spots were found in the chromato-
grams with Rf values in phenol of0O28 and 0-39 due to glutamic acid and
glycine respectively. Thus "X" is evidently a peptide consisting of glutamic
acid and glycine. It could be either y-glutamylglycine (y-glugly) or y-gluta-
mylglycylglycine (y-gluglygly). It is unlikely to be glycylglutamic acid since
this substance would be expected to give a yellow colour with ninhydrin as do
the glycyl dipeptides of glycine, serine and valine (Bowden, 1959). Samples of
y-glugly and y-gluglygly were prepared by methods of King and Kidd (1949)
and Kermack and Matheson (1957). These substances gave strong purple
ninhydrin-positive spots with Rf values of 0O32 (glugly) and 029 (gluglygly) in
phenol. After acid hydrolysis, y-gluglygly gave two spots with Rf values in
phenol of0O39 and0O27 due to glycine and glutamlc acid respectively. On paper
electrophoresis, y-glugly moved with the same mobility as authentic GSH
whereas y-gluglygly had the same mobility as the "X" product of Saunder's
reaction. Thus y-glutamylglycylglycine seems to be the main constituent of
" X ". Its mode of formation is obscure. It may have arisen from GSH by the
following reaction sequence:
gly Co gly -CO gly Co
CH-CH2SH -HwS C=CH., +H20 CH2 +HCHO
glu-NH glu-NHgIU _-i glu--NH glu NH glu-NH
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It seems less probable that y-gluglygly could have been formed in a transpeptida-
tion reaction. In biochemical systems, y-glutamylcysteine can transfer its
glutamyl group to other amino acids present in the medium. For instance,
Talalay (1954) observed the formation of y-glutamylglycine and y-glutamyl-
glutamic acid in a solution of GSH (pH 7.4) which had been incubated for 1 hr at
370 C. with Proteus vulgaris or with cell-free extracts of this organism. Since
traces of glycine have been detected among the products of reaction of GSH with
NSC, y-glutamylcysteine may be presumed to have been present at some stage
in the reaction. Further work will be required to determine the precise mode of
formation of y-gluglygly in the NSC in vitro system.
Thus we have obtained no definite evidence for the occurrence in vitro of an
oxidation product of GSH resembling tissue substance X. It will be noted how-
ever that traces of niaterials behaving like tissue substance X or GSH can be
seen in Fig. 6, B, C, D and E. These traces may have arisen in the in vitro
reactions described above but it seems more likely that they are due to small
amounts of GSH which have been carried over from the main " GSH " spot
in the paper sections containing " X" spot as selected for chromatographic
analysis.
(f) Stability of thiol peptide X in stored deep frozen phosphate extracts and
tissues.-Although a ninhydrin positive X spot can still be detected in electro-
pherograms of aged extracts of hepatocarcinogen-treated rat livers and tumours,
the mobility of the substance is no longer affected by NEM. An example of this
can be seen in Fig. 7A. Apparently the thiol group has become masked probably
through oxidation to disulphide or mixed disulphide. In view of the similar
mobilities of GSH and GSSG under our conditions it was reasonable to conclude
that XSH and XSSX would also have about the same mobilities.
An acid hydrolysate of X from a 2-month old extract of tannic acid-treated
rat liver showed definite traces of aspartic acid (turquoise colour with ninhydrin),
alanine and glycine as well as prominent spots due to glutamic and cysteic acids.
A similar picture was given by an hydrolysate of X obtained from a benzopyrene-
induced, tumour, with the exception that a spot corresponding to serine rather
than to alanine appeared in the chromatograms.
Wieland (1954) has noted that alanine may arise in hydrolysates of GSSG (in
the present work, however, alanine was never observed in hydrolysates ofauthentic
GSSG) as well as the expected spots due to glycine, glutamic acid and cysteine.
The occurrence ofaspartic acid and serine in some ofthe aged X products suggests
the formation of mixed disulphides of XSH with thiol peptides containing as-
partic acid or serine. No evidence has been obtained for the presence of such
peptides in any of our extracts nor have we observed the formation ofany nin-
hydrin-positive products with themobility of X in stored deep frozen extracts
of normal livers which were free of X when fresh.
Most of the stored extracts had been thawed, exposed briefly to the air and
refrozen several times, factors which may have contributed to changes in X.
The question as to whether X is a metabolically active material related to GSH
seems to deserve further study, but it must not be forgotten that the presence of
aspartic acid etc. might be explained on the basis of the in vitro formation of
ninhydrin-negative substances such as acetyl-aspartic acid having the same
mobility as X.
X, or a substance of similar mobility, has been found to survive for at least
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several months in deep frozen livers of hepatocarcinogen-treated rats. On the
other hand, a specimen of normal guinea-pig liver which initially gave a strong
X spot lost this material after several weeks at - 15° C. It is of interest that
substance X from a normal guinea-pig liver extract which had been stored for
10 days at 150 Ct. still responded completely to the addition of NEM. How-
ever, the intensity of the PE + GSH spot was unaffected by the NEM treatment.
Evidently all the GSH had been converted to GSSG whereas the thiol group of
substance X remained free.
2. Nature of Y spot
This small spot with mobility greater than that of aspartic acid was sometimes
found in hepatocarcinogen-treated rat liver extracts and invariably in rat tumour
extracts. It has not been extensively studied. It disappeared from electro-
pherograms of an Rd/3 tumour phosphate extract to which NEM had been
added, and the same effect was found with Y spot from normal guinea-pig liver
extract. It has already been noted that a small spot with mobility was detected
in electropherograms ofan old specimen ofGSH and similar products were observed
in GSH solutions subjected to ultraviolet irradiation or to the action of naphtha-
lene-2-sulphonyl chloride. These spots had about the same mobility as Y and
disappeared when NEMK was added.
A brownish spot appeared in the region of Y after spraying the electrophero-
gram from tannic acid-treated rat liver phosphate buffer extract with aniline
hydrogen phthalate spray (Partridge, 1949). This result suggests that a sugar-
containing residue may be present in close association with Y.
:3. Nature of Z spot in various rat tumours, in the livers of tumour-bearing rats and
in normal guinea-pig liver
Extracts of all rat tumours investigated have been found to contain a
ninhydrin-positive spot Z, examples of which are shown in Fig. 4 and in Fig. 7A.
Products of hydrolysis of Z spot from the BP tumour extract shown in Fig.
7A were chromatographed. The hydrolysate (Fig. 7B) contained appreciable
amounts of aspartic, glutamic and cysteic acids and lesser amounts of ninhydrin-
positive spots which have been tentatively identified as serine, glycine, proline,
a-alanine, valine, leucine, lysine and possibly arginine and histidine (compare
reference chromatogram Fig. 7C). Practically the same amino acid picture was
given by substance Z isolated from electropherograms of extracts of a rapidly
growing Rd/3 tumour or from a slow-growing DMBA tumour.
Unhydrolysed extracts ofZ from the three types ofrat tumour were submitted
to chromatography. In each case no spots due to free amino acids were detected
All that could be seen was a very minute intensely purple spot running at the
-phenol front and having zero Rf in the butanol direction. Thus Z is evidently a
protein or polypeptide-like material composed of at least 10 to 12 amino acids.
As already mentioned spots corresponding to Z were found in the livers of
rats bearing transplantable tumours, in normal guinea-pig liver and also in normal
rat kidney. However, when these spots were eluted and chromatographed there
always appeared a single strong reddish ninhydrin-positive spot with Rf values
similar to those of cysteine, as well as a minute purple spot running at the phenol
front. When liver or kidney Z spots were hydrolysed and chromatographed
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an amino acid picture qualitatively rather similar to that given by tumour Z
spot was obtained. The new spots apparently arose from the polypeptide moving
at the phenol front. It was noted that the cysteic acid spot in hydrolysates of
these Z spots was much more intense than in hydrolysates of material taken from
a region lying on the origin side of Z spot. Unhydrolysed material from this
position contained a polypeptide spot but no cysteine.
In spite ofthe rather sharp separation indicated in Fig. 7A it has been difficult
to determine to what extent tumour Z spot has been contaminated with ninhydrin-
positive material tailing from the origin towards Z spot. However it has been
found possible to remove Z spot as well as all other amino acids spots by washing
the electropherograms with several changes of deionised water. There remains
a tail of material directed towards the anode from the origin which is revealed by
staining with mercuric chloride-bromophenol blue or with ninhydrin. It probably
consists of protein.
The compact and isolated nature of Z spot as seen in Fig. 7A suggests that Z
spot is in fact a definite polypeptide entity unassociated with free amino acids.
It is certain that tumour Z spot cannot be due merely to the presence of a free
amino acid such as cysteine on a background of polypeptide or protein as seems
to be the case with the Z spot material from other tissues.
DISCUSSION
A thiol peptide X has been detected in the livers of rats injected with hepato-
carcinogens at times when the free phosphoethanolamine content of the liver is
maximal. Normal guinea-pig liver in contrast to normal rat liver already con-
tains appreciable amounts of a substance similar to and apparently identical with
X. Thiol peptide X contains the same amino acids as GSH but differs from GSH
in having a lower electrophoretic mobility. X might be an isomer of GCSH, a
homologue of GSH, a higher peptide with the same amino acid constituents as
GSH, or a derivative of GSH with some labile group. Various possibilities, some
of which are being studied in detail, are outlined below.
With regard to possible isomers of GSH in which the mode of linkage of the
constituent amino acids has been altered, little seems to be known. Du Vigneaud,
Loring and Miller (1937) synthesised oc-glutamylycysteinyl-glycine. However
this product (not known to occur naturally) retained its identity after liberation
from its insoluble cuprous mercaptide complex. In taking account of optical
isomers of GSH which might possibly have electrophoretic properties different
from that of naturally occurring GSH, L-y-glutamyl-L-cysteinylglycine, it is
noted that the isomer D-y-glutamyl-L-cysteinylglycine has been synthesised by
Kogl and Akkerman (1946). The authors could find no polarimetric evidence for
the occurrence of this substance in liver or tumour tissue. The fact that the
D-isomer could be isolated unchanged from its insoluble cuprous mercaptide
makes it unlikely that tissue substance X could be identical with this substance.
Ball, Revel and Cooper (1956) considered that y-glutamylglutathione might
be an intermediate in some transpeptidation reactions of GSH but apparently
this peptide has not been isolated from biochemical systems nor has it been
synthesised. It might fulfil the requirements for tissue substance X and indeed,
after making allowance for the barbitone hydrolysis artifact, it would appear
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that the glutamnic acid spot is more intense than either the glycine or cysteic
acid spot in hydrolysates of X as compared with hydrolysates of authentic GSH
(Fig. 2). In preliminary studies we have been able to effect separation of peptide
X from GSH in the volatile component (pyridine-acetic acid-water) electrolyte
recommended by Jirgl (1959). It is hoped with this method to obtain more
exact information about the proportions of the constituent amino acids of X
without interference from buffer artifacts.
The preponderance of glutamic acid in X nmight be due to the presence in the
spot of a ninhydrin-negative glutamic acid derivative having the same mobility
as X. One such contaminant might be pteroylglutamic (folic) acid which, on
electrophoresis, separates into two fluorescent components which travel towards
the anode. One of these components had the same mobility as X. It is quite
possible that such a contaminant of X would only reveal itself by its contribution
of extra glutamic acid in chromatograms of X hydrolysate.
Although a homologue of GSH (GCH2SH) containing homocysteine in place
of cysteine has been synthesised (Herrick and Todd, 1955; Gawron and Draus,
1959) this substance has apparently not been found in biochemical systems. Such
a compound with an extra -CH2 group in the thiol side chain might well have
properties similar to X. It might not be possible to distinguish GCH2SH from
GSH by chromatography of its hydrolysis products since homocysteic acid has
about the same Rf values as cysteic acid in Bowden's system. Like GSH, the
homologue would be expected to form an insoluble cuprous mercaptide. How-
ever, Herrick and Todd (1955) found that the cuprous mercaptide ofL-y-glutamyl-
DL-homocysteinylglycine is in fact easily soluble in water so the possibility cannot
be ruled out that thiol peptide X, if not GCH2SH, may at least be capable of
forming a water-soluble cuprous derivative and so be lost in the cuprous mer-
captide precipitation procedure.
There has been speculation as to the existence of a variety of interrelated
GSH derivatives including compounds with pyrrolidine and thiazoline rings
(Calvin, 1954; Isherwood, 1959). Pyrrolidine-imonium (PI) or hydroxy-
pyrrolidine (HP) forms of GSH proposed by Calvin (1954) have free thiol groups
but the a-amino group of the glutamyl residue has reacted with the y-carbonyl
group with loss of water (PI) or by simple addition (HP). According to Calvin,
HP could readily revert to the normal open chain form of GSH in the presence of
hydrogen ions. Thus the reaction of tissue substance X with NEM, its colour
reaction with ninhydrin-acetic acid and the apparent disappearance of X in the
acidic conditions required for cuprous mercaptide formation could be accounted
for if X possessed the hydroxypyrrolidine structure.
Thiol peptide X might be a GSH derivative with a substituent not readily
detectable chromatographically or easily lost during handling. Dubin and Rosen-
thal (1960) reported the isolation of a conjugate of GSH with spermidine from
E. coli. From the available information it would appear that this complex
consists of a molecule of GSSG which has reacted through its COOH groups with
the amino groups of spermidine. The conjugate ran as a single spot but after
hydrolysis it gave four spots due to glycine, glutamic acid, cysteic acid and
spermidine. In view ofthe elevated levels ofPE which occur in hepatocarcinogen-
treated rat liver it seemed that X might be a similar conjugate of GSH with PE
or ethanolamine. No chromatographic evidence has yet been obtained in favour
ofthe existence of such a conjugate, but it is highly likely that PE or ethanolamine
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residues would fail to survive thehydrolytic andfreeze-drying procedures employed
in the present study.
There are some indications in the literature that substances like thiol peptide
X have been detected in other situations. Thus Spicer and Weise (1955)
reported that a cationic fraction of guinea-pig or rabbit liver, submitted to paper
electrophoresis at pH 4-6, gave two unidentified ninhydrin-positive spots which
stood in the same relation to GSH, glutamic and aspartic acids as did substances
X and Y of the present study.
Waley (1956) found that an acidic fraction of calf lens contained several
peptides consisting of glutamic acid, cystine (or cysteine) and glycine. These
naterials were not identical with GSH and they appeared to contain differing
molar ratios of glycine to glutamic acid. Waley considered that one of these
peptides might carry a phosphate group.
Keir and Davidson (1956) reported that the cytidine monophosphate fraction
of rabbit tissues invariably gave a reaction with ninhydrin. When the fraction
was suibmitted to electrophoresis the ninhvdrin-positive constituent moved ahead
of cytidine monophosphate. On hydrolysis, the unknown constituent yielded
glutamic acid, cystine and glycine together with an unidentified base which
absorbed ultraviolet light.
Wthatever the nature of X and Y inay be, it appears that X at least may result
from some disruption ofthe normal course ofGSH metabolism in rat liver through
the influence of hepatocarcinogens or by the presence of a remote tumour.
Substances X and Y may theinselves play some part in tumour metabolism.
X may be a normal trace derivative of GSH which appears in increased amount
in rat liver under the stress conditions imposed by hepatocarcinogens or tumours.
Schacter and Law (1956) found that there is an increased requirement for GSH
from the liver, accompanied by an increased output of GSH by the liver, during
the growth of an ascitic forin of lymphocytic leukaemia in mice.
It is of considerable interest that a substance similar to thiol peptide X is
already present in appreciable amounts in the liver ofnormal guinea-pig, a species
which is refractory to hepatocarcinogenesis. Moreover, chromatographic evidence
has been obtained that 3'MeDAB injection failed to increase the level of free
PE in guinea-pig liver (Neish, unpublished results) whereas this hepatocarcinogen
induced a marked increase of PE in rat liver. These pronounced differences in
behaviour of X and PE in the livers of rat and guinea-pig may well be connected
with the susceptibility of the former and the refractoriness of the latter species
to hepatocarcinogenesis.
A significant relationship seems possible between the high level of GSH in
hepatocarcinogen-treated rat liver (at least in the initial stages; Fiala, 1958) and
the elevated PE content. Henneman, Altschule and Gouez (1955) found a
decrease in the level of inorganic phosphate in the serum after injection of GSH
into humans which suggests that the high level of GSH may be promoting phos-
phorylation reactions. Conversely, according to Jocelyn (1959) low GSH levels
may depress phosphorylation. Some evidence for this is found in the work of
Ling and Chow (1954) who showed that the blood and tissue levels of phospho-
lipids are abnormally low in Vitamin B12-deficient (low GSH) rats. It is interest-
ing that the enzyme alkaline phosphatase which catalyses the hydrolysis of
PE (PE may be the natural substrate for this enzyme, according to Dent, 1956)
is said to activated by GSSG and inhibited by GSH (Fell and Danielli, 1944).
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Thus the increased level of GSH in the liver of rats injected with 3'-MeIDAB
might be expected to favour the accumulation of PE which has in fact been
observed (Neish and Rylett, 1960).
Vollmer (1954) stated that GSH is lost from red blood cells in the presence of
methaemoglobinogenic agents. Since it is known that 3'-MeDAB induces
methaemoglobinemia in the rat (Neish, 1956) it seemedpossible that the formation
of thiol peptide X in rat liver might be connected with some disturbance in liver
GSH metabolism associated with the methaemoglobinogenic action of the azo
dye. However, such an effect can probably be ruled out because the equally
potent hepatocarcinogen, 4'-EtDAB, behaves exactly like 3'-MeDAB with regard
to the accumulation of PE and the formation of thiol peptide X in rat liver
although, compared with 3'-MeDAB on a mole for mole basis, it has no methaemo-
globinogenic activity in the rat (Neish, 1959).
The substance Z which has been found in extracts of rapid and slow growing
transplantable rat tumours and of benzopyrene-induced rat tumours seems to be
a protein or polypeptide. Borsook et al. (1949) obtained a polypeptide consisting
of 15 amino acids from the livers of various species. Several acidic peptide-
nucleotide complexes have been encountered by Steinberg et al. (1960) in mam-
malian liver and Agren (1960) has obtained an acid-soluble nucleotide-linked
peptide from trichloracetic acid extracts of ascites tumour cells. On hydrolysis,
this peptide gave particularly strong gly, glu, ser and asp spots, weaker spots
due to leu, iso-leu, lys, arg, threo and at least 4 more spots which were not
identified.
Tumour substance Z may be compared with the toxohormone of Nakahara
and Fukuoka (1958). Toxohormone is said to be produced by all malignant
tumours and its major amino acid components are stated to be ala, pro, asp,
arg, Oala, lys, leu andglu. A toxohormone-like material isolated from the urine of
cancer patients by Fuchigami, Umeda and Ono (1956) contained asp, glu, ser,
threo, pro, ala, lys, val, leu, 0ala, cystine and gly all of which with the exception
of threo and 0ala appear to occur in Z. Whether Z further resembles toxo-
hormone in having catalase-inhibiting properties remains to be determined.
It is of interest that hepatocarcinogens induce the formation of a thiol peptide
X and of excessive amounts ofphosphoethanolamine in rat liver. Rat sarcomas
appear to have a higher level of PE than normal rat muscle tissue (Neish, un-
published results) and they also contain thiol peptide X which is not present in
normal muscle. These observations suggest that it might be worthwhile to
examine the possibility of the emergence of tumour-type metabolic patterns even
in the early stages of the action of a carcinogen on its target organ. Recently,
K6gl et al. (1960) stated that the lecithin fraction ofprimary rat tumours induced
by 4-dimethylaminoazobenzene incorporated considerably more 32p in vitro
than did the phosphatidylethanolamine fraction. The opposite situation was
found with normal liver tissue. Thus a shift in the metabolic activities of both
phosphatides appears to occur during development of liver tumours. It has
already been noted (Neish and Rylett, 1960) that a possible explanation for the
accumulation ofPE in the livers ofhepatocarcinogen-injected rats lies in a carcino-
gen-induced failure of the enzymic mechanism for phosphatidylethanolamine
synthesis. Kogl's work suggests that a similar defect may be present in the
azo-dye induced tumours. Thus an early effect of the carcinogen may persist
through the course of hepatocarcinogenesis.
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SUMMARY
1. The livers of hepatocarcinogen-treated rats and of normal guinea-pigs
contain a substance X which is apparently a thiol peptide closely related to
glutathione. A similar substance has been detected in transplantable and induced
rat tumours together with a substance Y which may also be a thiol peptide.
Attempts to characterise X fully have not yet been successful but some pointers
towards its possible nature have been obtained.
2. All the rat tumours investigated contained a substance Z which seems to be
a protein or polypeptide containing at least 10 to 12 amino acids.
Thanks are due to Miss P. Ingleton for a gift of the benzopyrene-induced rat
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REFERENCES
AGREN, G.-(1960) Acta chem. scand., 14, 2065.
BALL, E. G., REVEL, J. P. AND COOPER, O.-(1956) J. biol. Chem., 221, 895.
BENESCH, R., BENESCH, R. E., GUTCHO, M. AND LAUFER, L.-(1960) Science, 123, 981.
BLASS, J., LE COMTE, 0. AND POLONOVSKI, J.-(1954) Bull. Soc. Chim. biol., Paris, 36,
627.
BORSOOK, H., DEASY, C. L., HAAGEN-SMIT, A. J., KEIGHLEY, G. AND Lowy, P. H.-
(1949) J. biol. Chem., 179, 705.
BOWDEN, C. H.-(1959) Clin. Chim. Acta, 4, 539.
BOYLAND, E. AND MAWSON, E. H.-(1938) Biochem. J., 32, 1460.
CALVIN, M.-(1954) 'Glutathione'. Ed. S. Colowick et al. New York (Academic
Press Inc.), p. 3.
DENT, C. E.-(1956) Ciba Symposium-Bone Structure and Metabolism. London
(Churchill), p. 266.
DUBIN, D. T. AND ROSENTHAL, S. M.-(1960) Fed. Proc., 19, Part 1, p. 1.
Du VIGNEAUD, V., LORING, H. S. AND MILLER, G. L.-(1937) J. biol. Chem., 118, 391.
FELL, H. B. AND DANIELLI, J. F.-(1944) Bull. War Med., 4, 253.
FIALA, S.-(1958) Nature, Lond., 182, 257.
FRIEDMANN, E., MARRIAN, D. H. AND SIMON-REUSS, I.-(1949) Brit. J. Pharmacol.,
4, 105.
FUCHIGAMI, A., UMEDA, M. AND ONO, T.-(1956) Gann., 47, 295.
GAWRON, 0. AND DRAUS, F. (1959) J. org. Chem., 24, 1392.
GREGORY, J. D. (1955) J. Amer. chem. Soc., 77, 3922.
GUTCHO, M. AND LAUFER, L.-(1954) 'Glutathione . Ed. S. Colowick et al. NewA
York (Academic Press Inc.), p. 79.
HENNEMAN, D. H., ALTSCHULE, M. D. AND GOUCZ, R. M.-(1955) Mietabolism, 4, 433.
HERRICK, E. C. AND TODD, C. W.-(1955) U.S. Pat. Syst. Leaft., No. 2,723,972 and
2,723,973.
ISHERWOOD, F. A.-(1959) Biochem. Soc. Symp. No. 17, Glutathione. London (Cam-
bridge University Press), p. 13.
JIRGL, V.-(1959) Experientia, 15, 235.
JOCELYN, P. C.-(1959) Biochem. Soc. Symp. No. 17, Glutathione. London (Cambridge
University Press), p. 60.
KEIR, H. M. AND DAVIDSON, J. N. (1956) Biochem. J., 63, 23P.
KERMACK, W. 0. AND MATHESON, N. A.-(1957) Ibid., 65, 45.
KING, F. E. AND KIDD, D. A. A. (1949) J. chem. Soc.. p. 3315.646 WY J. P. NEISH AND ANN RYLETT
K6GL, F. AND AKKERMAN, A. M.-(1946) Rec. Trav. chim. Pays-bas, 65, 216, 225.
Idem, SMAK, C., VEERKAMP, J. H. AND VAN DEENEN, L. L. M.-(1960) Z. Krebsforsch..
63, 558.
LING. C. T. AND CHOW, B. F. (1954) J. biol. Chem., 206, 797.
NAKAHARA, W. AND FUKUOKA, F.-(1958) Advanc. Cancer Res., 5, 157.
NEISH. W. J. P. (1956) Nature, Lond., 178, 1350.-(1959) Naturwissensehaften, 46, 535.
Idem AND RYLETT, A. (1960) Brit. J. Cancer, 14, 737.
PARTRIDGE, S. M. (1949) Nature, Lond., 164, 443.
SAUBERLICH, H. E. AND BAUMANN, C. A.-(1951) Cancer Res., 11, 67.
SAUNDERS, B. C. (1933) Biochern. J., 27, 397. (1934) Ibid., 28, 1977.
SCHACTER, B. AND LAW, L. W.-(1956) J. nat. Cancer Ilnst., 17, 391.
SPICER, S. S. AND WEISE, V. (1955) Euzymologia, 17, 263.
STEINBERG, D., VAUGHAN, M., SHERMAN, F. G. AND O'DELL, B. L.-(1960) Biochim.
biophys. Acta, 40. 225.
TALALAY, P. S.-(1954) Nature, Lond., 174, 516.
VOLLMER, E. P.-(1954) Glutathione'. Ed. S. Colowick et al. New York (Academic
Press Inc.), p. 186.
WAELSCH. H. AND RITTENBERG, D.-(1941) J. biol. Chem., 139, 761.
WALEY, S. G. (1956) Biochem. J., 64, 715. (1957) Ibid., 67, 172.
WIELAND, T. (1954) 'Glutathione'. Ed. S. Colowick et al. NewvYork (Academic
Press Inc.). p. 55.
WVOODWARD, G. F-.-(1933) Biochem. J., 27, 1411.